|
carbon monoxide |
|---|---|
| Trade Name | |
| Orphan Indication | Sickle cell anemia |
| USA Market Approval | USA |
| USA Designation Date | 2012-09-28 00:00:00 |
| Sponsor | Hillhurst Biopharmaceuticals, Inc.;2029 Verdugo Blvd, Suite 125;Montrose, California, 91020 |
Related Access Program
